Latest News On Out-Of-Pocket Costs

Latest KFF Health News Stories

California’s Expanded Health Coverage for Immigrants Collides With Medicaid Reviews

KFF Health News Original

A state policy to extend Medi-Cal to qualified Californians without legal residency is running up against a federal requirement to resume eligibility checks. The redetermination process is causing many Latinos, who make up a majority of Medi-Cal beneficiaries, to be disenrolled.

When Copay Assistance Backfires on Patients

KFF Health News Original

Drugmakers offer copay assistance programs to patients, but insurers are tapping into those funds, not counting the amounts toward patient deductibles. That leads to unexpected charges. But the practice is under growing scrutiny.

Si eres pobre, un tratamiento de fertilidad suele ser un sueño inaccesible

KFF Health News Original

Pero las personas con ingresos más bajos, a menudo de minorías, tienen más probabilidades de estar cubiertas por Medicaid o por seguros limitados que no tienen esta cobertura.

Out for Blood? For Routine Lab Work, the Hospital Billed Her $2,400

KFF Health News Original

Convenient as it may be, beware of getting your blood drawn at a hospital. The cost could be much higher than at an independent lab, and your insurance might not cover it all.

Nueva ley de California ofrece protección contra facturas por viajes en ambulancia

KFF Health News Original

En California, casi tres cuartas partes de los traslados de emergencia en ambulancia generan facturas fuera de la red. La factura sorpresa promedio es de $1,209, la más alta del país

New California Law Offers Fresh Protection From Steep Ambulance Bills

KFF Health News Original

The law, which takes effect Jan. 1, prohibits out-of-network ground ambulance operators from billing patients more than they would pay for in-network rides. It also caps how much the uninsured must pay.

Pzifer y Moderna presionan por un nuevo refuerzo contra covid. ¿Deberías recibirlo? Los CDC están por decidir

KFF Health News Original

A pesar de las amplias recomendaciones para el refuerzo anticovid actualizado publicadas el otoño pasado, sólo el 17% de la población la recibió, y alrededor del 43% de las personas de 65 años o más.

New Weight Loss Drugs Carry High Price Tags and Lots of Questions for Seniors

KFF Health News Original

Although nearly 40% of Americans 60 and older are obese, Medicare doesn’t cover weight loss medications. Meanwhile, studies haven’t thoroughly examined new drugs’ impact on older adults.

¿Cuánto costará la píldora anticonceptiva de venta libre? ¿La cubrirán los seguros?

KFF Health News Original

Los defensores de la salud reproductiva celebraron esta histórica aprobación como un paso que puede ayudar a millones de personas a evitar embarazos no deseados, que ocurren casi la mitad de las veces en los Estados Unidos.

An Arm and a Leg: A $229,000 Medical Bill Goes to Court

Podcast

Lisa French was told her surgery would cost $1,337. But the hospital sent her a bill for $229,000, then sued her. The case went all the way to the Colorado Supreme Court. The court’s ruling could have major implications for determining a “reasonable price” in health care.

Decisión de Eli Lilly de bajar el precio de su insulina logrará cambios históricos en los costos

KFF Health News Original

Expertos en precios de medicamentos celebraron la noticia de Eli Lilly y otros esfuerzos. Y estas otras iniciativas para llevar al mercado insulina de menor costo, a su vez, presionarían a Eli Lilly para que mantuviera sus precios bajos.

Eli Lilly Slashed Insulin Prices. This Starts a Race to the Bottom.

KFF Health News Original

Eli Lilly’s news that it plans to cut insulin costs for patients will help, not hinder, the recent efforts in California and by entrepreneurs such as Mark Cuban to offer lower-cost alternatives, drug pricing experts said.

After Capping Insulin Copays, Colorado Sets Its Sights on EpiPens

KFF Health News Original

Colorado’s proposed legislation to cap the copay for the EpiPen is part of a nationwide trend as more states try to shield patients from skyrocketing drug prices.